Electromed Company Insiders

ELMD Stock  USD 16.39  0.67  4.26%   
Electromed employs about 170 people. The company is managed by 15 executives with a total tenure of roughly 101 years, averaging almost 6.0 years of service per executive, having 11.33 employees per reported executive. Evaluation of Electromed's management performance can provide insight into the firm performance.
Kathleen Skarvan  CEO
CEO and President and Director
George Winn  Chairman
Vice Chairman of the Board
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.

Electromed's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Electromed's future performance. Based on our forecasts, it is anticipated that Electromed will maintain a workforce of about 170 employees by May 2024.
 
Credit Downgrade
 
Yuan Drop
 
Covid

Electromed Management Team Effectiveness

The company has return on total asset (ROA) of 0.0721 % which means that it generated a profit of $0.0721 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.104 %, meaning that it created $0.104 on every $100 dollars invested by stockholders. Electromed's management efficiency ratios could be used to measure how well Electromed manages its routine affairs as well as how well it operates its assets and liabilities. As of April 24, 2024, Return On Tangible Assets is expected to decline to 0.04. In addition to that, Return On Capital Employed is expected to decline to 0.08. At present, Electromed's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 45.6 M, whereas Non Current Assets Total are forecasted to decline to about 5.4 M.
The current year's Net Income Applicable To Common Shares is expected to grow to about 3.8 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 8.8 M.

Electromed Workforce Comparison

Electromed is rated below average in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 7,060. Electromed holds roughly 170 in number of employees claiming about 2.41% of equities under Health Care industry.

Electromed Profit Margins

The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.17 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.17.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.60.68
Fairly Down
Pretty Stable

Electromed Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Electromed insiders, such as employees or executives, is commonly permitted as long as it does not rely on Electromed's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Electromed insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2023-09-01
4.0
4
1
 277,000 
 1,107 
2023-03-01
0.5
2
4
 65,000 
 130,000 
2020-06-01
0.6667
4
6
 50,500 
 98,684 
2017-12-01
0.625
5
8
 10,000 
 37,928 
2017-09-01
0.25
4
16
 90,000 
 271,460 
2012-06-01
4.0
4
1
 42,175 
 6,800 
2012-03-01
2.0
10
5
 54,896 
 18,550 
2011-09-01
1.0
1
1
 6,000 
 0.00 
2011-03-01
2.0
2
1
 28,000 
 12,000 
2010-12-01
0.6667
2
3
 1,825 
 0.00 
2010-09-01
0.375
3
8
 97,500 
 70,000 

Electromed Notable Stakeholders

An Electromed stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Electromed often face trade-offs trying to please all of them. Electromed's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Electromed's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kathleen SkarvanCEO and President and DirectorProfile
George WinnVice Chairman of the BoardProfile
Stephen CraneyIndependent Chairman of the BoardProfile
James CunniffDirector PresidentProfile
Jeremy BrockCFOProfile
Thomas HagedornIndependent DirectorProfile
Stan EricksonIndependent DirectorProfile
William EcklesIndependent DirectorProfile
Lee JonesDirectorProfile
Amy YantaQuality AffairsProfile
Diane KaufmanVice ResourcesProfile
Brad NagelChief OfficerProfile
William GeorgeSecretaryProfile
Christopher HollandChief OfficerProfile
Bradley NagelChief OfficerProfile

About Electromed Management Performance

The success or failure of an entity such as Electromed often depends on how effective the management is. Electromed management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Electromed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Electromed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.06  0.04 
Return On Capital Employed 0.1  0.08 
Return On Assets 0.06  0.04 
Return On Equity 0.08  0.06 
The data published in Electromed's official financial statements usually reflect Electromed's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Electromed. For example, before you start analyzing numbers published by Electromed accountants, it's critical to develop an understanding of what Electromed's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Electromed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Electromed's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Electromed's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Electromed. Please utilize our Beneish M Score to check the likelihood of Electromed's management manipulating its earnings.

Electromed Workforce Analysis

Traditionally, organizations such as Electromed use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Electromed within its industry.

Electromed Manpower Efficiency

Return on Electromed Manpower

Revenue Per Employee282.7K
Revenue Per Executive3.2M
Net Income Per Employee18.6K
Net Income Per Executive211.1K
Working Capital Per Employee174.9K
Working Capital Per Executive2M
When determining whether Electromed is a strong investment it is important to analyze Electromed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Electromed's future performance. For an informed investment choice regarding Electromed Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Complementary Tools for Electromed Stock analysis

When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Is Electromed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.727
Earnings Share
0.45
Revenue Per Share
6.072
Quarterly Revenue Growth
0.167
Return On Assets
0.0721
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.